Triastek - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Judge blocks Pentagon from blacklisting Anthropic: ‘Classic First Amendment retaliation’

Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform

Representative image of a laboratory skin research setting illustrating the kind of translational science behind Rubedo Life Sciences’ RLS-1496 Phase 1 dermatology results in psoriasis, atopic dermatitis, and skin aging.

Aging biotech just got a real skin test and Rubedo Life Sciences may have passed the first one

Can deeper university alliances help Propanc Biopharma, Inc. stabilize its clinical transition?

Read More

4 minute read

Pharma Industry News

Triastek’s 3D-printed D23 tablet shows strong clinical results for IgAN treatment

Triastek has reported promising clinical results for its 3D-printed drug delivery product, D23 (Budesonide Ileum Targeted Tablets), which…

byPallavi Madhiraju

February 23, 2025

web analytics